This message was sent to ##Email##
|
|
|
|
|
|
As 2018 comes to a close, AST would like to wish its members, partners and other transplant professionals a safe and happy holiday season. As we reflect on the past year for the field, we would like to provide the readers of the AST eNews a look at the most accessed articles from the year. Our regular publication will resume Jan. 4.
|
TIME
April 27: Dr. Giuliano Testa, a Baylor University Medical Center surgeon has earned a spot on the TIME 100 list, the magazine's annual assessment of the most influential people in the world.
READ MORE
ATC
June 15: Uterus Transplantation (UTx) is the first available treatment for women with Absolute Uterine Infertility (AUI). It allows the affected female to carry her own pregnancy and deliver a baby. As the first center in the U.S. we can report a delivery of a healthy baby.
READ MORE
American Journal of Transplantation
Sept. 14: Delayed graft function (DGF) is a risk factor for acute rejection (AR) in renal transplant recipients and KDIGO guidelines suggest use of lymphocyte depletion induction when DGF is anticipated. We analyzed the UNOS/OPTN database to assess the impact of induction immunosuppression on the risk of AR in deceased kidney recipients based on pre‐transplant risk of DGF using a validated model.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
Transplantation
July 20: The best approach for determining whether a transplant program is delivering high-quality care is unknown. This review aims to identify and characterize quality metrics in solid organ transplantation.
READ MORE
American Journal of Transplantation
Jan. 12: With advances in immunosuppression, graft and patient outcomes after kidney transplantation have improved considerably. As a result, long-term complications of transplantation, such as urologic malignancies, have become increasingly important. Kidney transplant recipients, for example, have a 7-fold risk of renal cell carcinoma (RCC) and 3-fold risk of urothelial carcinoma (UC) compared with the general population.
READ MORE
|
|
American Journal of Transplantation
July 27: Social support is used to determine transplant eligibility despite lack of an evidence base and vague regulatory guidance. It is unknown how many patients are disqualified from transplantation due to inadequate support, and whether providers feel confident using these subjective criteria to determine eligibility.
READ MORE
The New York Times
Feb. 9: For the first time in the United States, a woman who had a uterus transplant has given birth. The mother, who was born without a uterus, received the transplant from a living donor last year at Baylor University Medical Center in Dallas, and had a baby boy there last month, the hospital said on Friday.
READ MORE
|
The study is designed to explore an investigational drug-maribavir-in stem cell transplant and solid organ transplant recipients whose CMV infections are not responding to current treatments. This investigational drug is given as an oral pill. Please visit to learn more about the SOLSTICE study.
|
|
|
|
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
Transplantation
March 16: Velma Scantlebury, MD, says, "I had an assignment at a young age to write an essay on “My Career”. Even at age 10 years, I wanted to help others, learn about what makes you sick, but most importantly, I wanted to be my own boss. I saw the only doctor I interacted with at that time, my pediatrician, and he worked for himself. That’s what I wanted to do."
READ MORE
Transplantation
Jan. 26: We review contemporary coagulation management for patients undergoing liver transplantation. A better understanding of the complex physiologic changes that occur in patients with end-stage liver disease has resulted in significant advances in anesthetic and coagulation management. A group of internationally recognized experts have critically evaluated current approaches for coagulopathy detection and management.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
